Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schott

Showing results (471-480 of 864) with videos related to

Pageof 87
Sort By:
Journal of Neurology|February 3, 2018
Primary progressive aphasia: a clinical approachCharles R Marshall, Chris J D Hardy, Anna Volkmer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 1, 2020
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassaysAshvini Keshavan, Henrietta Wellington, Zhongbo Chen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 13, 2023
Alzheimer's disease marker phospho-tau181 is not elevated in the first year after moderate-to-severe TBINeil Graham, Karl Zimmerman, Amanda J Heslegrave, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2026
The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PETAshvini Keshavan, Katharine Wiltshire, Ryan Wee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?Ross W Paterson, Jamie Toombs, Miles D Chapman, et al.
Neuroimage. Clinical|November 18, 2019
Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian processLiane S Canas, Carole H Sudre, Enrico De Vita, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 18, 2024
Associations of life-course cardiovascular risk factors with late-life cerebral hemodynamicsMathijs Bj Dijsselhof, Jorina Holtrop, Sarah-Naomi James, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 15, 2019
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive questMartha S Foiani, Claudia Cicognola, Natalia Ermann, et al.
Human Brain Mapping|March 26, 2018
Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imagingThomas D Parker, Catherine F Slattery, Jiaying Zhang, et al.
Neurobiology of Aging|September 4, 2013
Validation of next-generation sequencing technologies in genetic diagnosis of dementiaJohn Beck, Alan Pittman, Gary Adamson, et al.
Pageof 87

Showing results (471-480 of 864) with videos related to

Sort By:
Pageof 87
Journal of Neurology|February 3, 2018
Primary progressive aphasia: a clinical approachCharles R Marshall, Chris J D Hardy, Anna Volkmer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 1, 2020
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassaysAshvini Keshavan, Henrietta Wellington, Zhongbo Chen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 13, 2023
Alzheimer's disease marker phospho-tau181 is not elevated in the first year after moderate-to-severe TBINeil Graham, Karl Zimmerman, Amanda J Heslegrave, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2026
The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PETAshvini Keshavan, Katharine Wiltshire, Ryan Wee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?Ross W Paterson, Jamie Toombs, Miles D Chapman, et al.
Neuroimage. Clinical|November 18, 2019
Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian processLiane S Canas, Carole H Sudre, Enrico De Vita, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 18, 2024
Associations of life-course cardiovascular risk factors with late-life cerebral hemodynamicsMathijs Bj Dijsselhof, Jorina Holtrop, Sarah-Naomi James, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 15, 2019
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive questMartha S Foiani, Claudia Cicognola, Natalia Ermann, et al.
Human Brain Mapping|March 26, 2018
Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imagingThomas D Parker, Catherine F Slattery, Jiaying Zhang, et al.
Neurobiology of Aging|September 4, 2013
Validation of next-generation sequencing technologies in genetic diagnosis of dementiaJohn Beck, Alan Pittman, Gary Adamson, et al.
Pageof 87